WWOX and melanoma: Treatment with the Zfra peptide significantly reduces the expression of pS14-WWOX in the lungs and brains of mice, thereby preventing the pulmonary metastasis of B16F10 melanoma cells and mitigating melanoma-induced neurodegeneration in the hippocampus, as well as the formation of cortical plaques.